San Francisco, CA7 Active Studies

Retinitis Pigmentosa Clinical Trials in San Francisco, CA

Find 7 actively recruiting retinitis pigmentosa clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
7
Sponsors
3,549
Enrolling

Recruiting Retinitis Pigmentosa Studies in San Francisco

NCT01561157Recruiting

Longitudinal Study of the Porphyrias

The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in peopl...

San Francisco, CA1,500 participantsThe American Porphyrias Expert Collaborative
View Study Details
NCT06136650Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

The purpose of this study is to assess the efficacy and safety of opevesostat plus hormone replacement therapy (HRT) compared to alternative abiraterone acetate or enzalutamide in participants with Me...

San Francisco, CAPHASE31,314 participantsMerck Sharp & Dohme LLC
View Study Details
NCT00254605Recruiting

Retinal Imaging in Patients With Inherited Retinal Degenerations

The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive...

San Francisco, CA400 participantsUniversity of California, San Francisco
View Study Details
NCT07159841Recruiting

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperp...

San Francisco, CAPHASE2153 participantsCrinetics Pharmaceuticals Inc.
View Study Details
NCT04883905Recruiting

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effec...

San Francisco, CA150 participantsAlnylam Pharmaceuticals
View Study Details
NCT07536269Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

The main objective of this study is to assess the safety and tolerability of crinecerfont in pediatric participants 3 months to \<4 years of age with CAH....

San Francisco, CAPHASE220 participantsNeurocrine Switzerland GmbH
View Study Details
NCT06658899Recruiting

A Phase 2 Study of CRD-4730 in CPVT

This is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynam...

San Francisco, CAPHASE212 participantsCardurion Pharmaceuticals, Inc.
View Study Details

About Retinitis Pigmentosa Clinical Trials in San Francisco

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 7 retinitis pigmentosa clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 3,549 participants. Research is being sponsored by The American Porphyrias Expert Collaborative, Merck Sharp & Dohme LLC, University of California, San Francisco and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in San Francisco — FAQ

Are there retinitis pigmentosa clinical trials in San Francisco?

Yes, there are 7 retinitis pigmentosa clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 7 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated October 15, 2026 from ClinicalTrials.gov